1. Home
  2. ARTW vs HIND Comparison

ARTW vs HIND Comparison

Compare ARTW & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Art's-Way Manufacturing Co. Inc.

ARTW

Art's-Way Manufacturing Co. Inc.

HOLD

Current Price

$2.48

Market Cap

13.4M

Sector

Industrials

ML Signal

HOLD

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

N/A

Current Price

$2.13

Market Cap

15.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTW
HIND
Founded
1956
2017
Country
United States
United States
Employees
N/A
18
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
15.2M
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
ARTW
HIND
Price
$2.48
$2.13
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
8.9K
13.9K
Earning Date
04-13-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
233.33
N/A
EPS
0.04
N/A
Revenue
$22,975,408.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$64.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.04
$1.75
52 Week High
$4.69
$12.87

Technical Indicators

Market Signals
Indicator
ARTW
HIND
Relative Strength Index (RSI) 40.65 45.12
Support Level $2.07 $1.99
Resistance Level $2.52 $2.36
Average True Range (ATR) 0.11 0.11
MACD -0.01 0.00
Stochastic Oscillator 16.67 8.00

Price Performance

Historical Comparison
ARTW
HIND

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: